Anti-PD1-induced collagenous colitis in a melanoma patient-Reference-Cited by-同舟云学术

Anti-PD1-induced collagenous colitis in a melanoma patient

Published:2016-06 Issue:3 Volume:26 Page:308-311
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Baroudjian Barouyr,Lourenco Nelson,Pagès Cécile,Chami Ichrak,Maillet Marianne,Bertheau Philippe,Bagot Martine,Gornet Jean-Marc,Lebbé Céleste,Allez Matthieu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference15 articles.

1. Ipilimumab-induced perforating colitis;Mitchell;J Clin Gastroenterol,2013

2. Refractory colitis following anti-CTLA4 antibody therapy: analysis of mucosal FOXP3+ T cells;Lord;Dig Dis Sci,2010

3. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4;Beck;J Clin Oncol,2006

4. Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis;Minor;Cancer Biother Radiopharm,2009

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follow-up biopsies in gastrointestinal immune checkpoint inhibitor toxicity may show markedly different inflammatory patterns than initial injury;Human Pathology;2024-06

2. Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogo;Revista de Gastroenterología de México;2024-01

3. Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologist;Revista de Gastroenterología de México (English Edition);2024-01

4. Histopathologic Manifestations of Immune Checkpoint Inhibitor Therapy-Associated Gastrointestinal Tract Injury;Surgical Pathology Clinics;2023-12

5. Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management;International Journal of Molecular Sciences;2023-07-15